Jaguar Health Inc.’s stock tumbled 66% Tuesday, after the biotech said a late-stage trial of a drug that aims to prevent diarrhoea in cancer patients undergoing treatment failed to meet its main goal ...
Original Image Link
Source:www.msn.com
Original Image Link
Source:www.msn.com
Posted: 2024-07-23 07:56:00